TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
27 hedge funds and large institutions have $2.9M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 9 closing their positions.
Holders
27
Holders Change
-5
Holders Change %
-15.63%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
3
Reduced
4
Closed
9
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
-$98K
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$216K |
2 |
HF
2
HRT Financial
New York
|
$14K |
3 |
VF
3
Virtu Financial
New York
|
$8K |
4 |
4
Millennium Management
New York
|
$6.16K |
5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$3.04K |